The world of vaccines is currently entering a very dynamic era amidst the COVID-19 pandemic. Since the SARS-CoV-2 virus first appeared in late 2019, efforts have been made to develop an effective vaccine. Currently, there are various vaccines that have received emergency use permits from health authorities in various countries, such as Pfizer-BioNTech, Moderna, AstraZeneca, and Sinovac. Vaccine development is not just limited to large pharmaceutical companies. Many countries, including India, Russia and China, are also playing an active role in creating and producing vaccines. These vaccines are expected to provide protection against viral infections and reduce symptoms of severe disease. In terms of efficacy, mRNA vaccines such as Pfizer and Moderna show a high level of effectiveness, namely around 94-95%. However, the importance of vaccination must still be accompanied by public awareness about the implementation of health protocols. Recent data shows that vaccination has helped reduce the number of new cases and deaths from COVID-19 in many countries. Vaccine distribution is also a big challenge. Low-income countries often have difficulty getting vaccine shots. Therefore, initiatives such as COVAX were launched to ensure equitable distribution of vaccines across the world. Despite this, criticism regarding injustice in vaccine access is still widely expressed. The development of new variants of the virus, such as Delta and Omicron, raises new concerns. This variant shows its ability to evade immunity generated by vaccines and previous infections. Therefore, several vaccine companies are developing boosters or modified vaccines to increase protection against this variant. Meanwhile, research on vaccines for children also shows promising results. Several vaccines have received approval to be given to children aged 5 years and over. This allows more individuals to receive protection, as well as contributing to the creation of herd immunity. The next challenge is regarding the use of vaccines in countries with inadequate health surveillance. Public education regarding the importance of vaccination must be increased, so that they understand the benefits and overcome issues of misinformation circulating. Readiness for mass vaccination is also a major focus in many countries. Vaccine distribution infrastructure and logistics must be strengthened to reach the population effectively. Countries that have successfully implemented vaccination programs have become examples for others. Innovations in vaccine production are also noteworthy. Technologies such as Viral Vector Based Vaccines and Recombinant Protein Vaccines continue to be developed to increase vaccine efficiency and safety. This is an important step in dealing with possible future pandemics. Finally, international collaboration in vaccine research and development is essential. By sharing data and resources, countries can respond more quickly to new virus threats. It is hoped that the involvement of global health organizations, such as WHO, can accelerate the process of disseminating knowledge and technology related to vaccines. It is hoped that these steps will speed up the world’s post-pandemic recovery and ensure that vaccines are available to all, ending a crisis that has disrupted the lives of many people.